Profile
Scott Moorefield served as the Senior Vice President of Business Development at Silverback Therapeutics, Inc. and as the Chief Business Officer at Boundless Bio, Inc. from 2019 to 2020.
He holds a doctorate degree from North Carolina State University, which he received in 2005, and an undergraduate degree from The University of North Carolina at Chapel Hill, which he received in 1996.
Former positions of Scott Moorefield
| Companies | Position | End |
|---|---|---|
| ARS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2022-02-28 |
| BOUNDLESS BIO, INC. | Corporate Officer/Principal | 2020-05-31 |
Training of Scott Moorefield
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
| North Carolina State University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BOUNDLESS BIO, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson January 4, 2016 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Scott Moorefield
